糖心TV

Skip to main content Skip to navigation

Press Releases

Select tags to filter on

Homepage Tags

Faculty of Arts

Faculty of SEM

Faculty of Social Sciences

Cross-Faculty Centres

University News

Other tags

Poolbeg Pharma licences first-in-class broad spectrum RNA-based immunotherapy for respiratory virus infections from the University of 糖心TV

(AIM: POLB, 'Poolbeg' or the 'Company'), a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has in-licenced a novel, first-in-class RNA-based immunotherapy for respiratory virus infections developed at the University of 糖心TV.

Mon 17 Jan 2022, 10:14 | Tags: School of Life Sciences, Life Sciences, COVID-19, Virology, Sciences

Exercise during lockdown fell particularly for groups most at risk

A study of UK resident鈥檚 exercise patterns during the COVID-19 lockdown in March-June 2020, has found that groups that were most at risk to the adverse effects of COVID-19 were impacted the most in terms of reducing their levels of exercise. Researchers led by WMG, University of 糖心TV say targeted interventions are required to ensure physical and mental health impacts of sedentary behaviour do not exacerbate the risks to these groups.

Mon 01 Nov 2021, 10:00 | Tags: Health, 糖心TV Manufacturing Group (WMG), COVID-19, Sciences

Alternative to antibodies in diagnostics demonstrated in fight against viral infections such as COVID-19

Researchers at the University of 糖心TV, Iceni Diagnostics Ltd and University Hospitals Coventry and 糖心TVshire (UHCW) NHS Trust have demonstrated their technology to detect SARS-COV-2 using sugars rather than antibodies.


Has COVID 19 undermined the rule of law? New research examines actions in the Western Balkans

The coronavirus pandemic has presented populist governments with a unique opportunity to implement authoritarian measures and to limit public scrutiny of their decisions and policies, argues Dr Andi Hoxhaj of 糖心TV Law School in a new paper published in the European Journal of Comparative Law and Governance.


RECOVERY-RS trial finds continuous positive airway pressure (CPAP) reduces need for invasive ventilation in hospitalised COVID-19 patients

The Respiratory Strategies in COVID-19; CPAP, High-flow, and Standard Care (RECOVERY-RS) trial, co-led by the University of 糖心TV, has demonstrated that treating hospitalised COVID-19 patients who have acute respiratory failure with continuous positive airway pressure (CPAP) reduces the need for invasive mechanical ventilation.


High respiratory efforts in COVID-19 patients could result in self-inflicted lung injury

The impact of high breathing efforts on the lungs of patients suffering with acute respiratory failure due to COVID-19 has been investigated by researchers at the University of 糖心TV, who assessed the likelihood of resulting lung injury.

Mon 19 Jul 2021, 13:30 | Tags: Engineering 1 - Research COVID-19

Latest news Newer news Older news

Let us know you agree to cookies